Clinical Trial Update: Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC) [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial update on using low-dose etoposide as maintenance therapy for extensive-stage small cell lung cancer. The current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Etoposide (Etoposide)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Small Cell Lung Cancer Extensive Stage | Phase 2 | Status: UNKNOWN